Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting

The absence of axonal regeneration after spinal cord injury (SCI) has been attributed to the up-regulation of axon-repelling molecules, such as chondroitin sulfate proteoglycans (CSPGs) present in the glial scar that forms post-SCI. We previously identified the transcription factor SOX9 as a key up-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2016-09, Vol.283 (Pt A), p.1-15
Hauptverfasser: McKillop, William M., York, Elisa M., Rubinger, Luc, Liu, Tony, Ossowski, Natalie M., Xu, Kathy, Hryciw, Todd, Brown, Arthur
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15
container_issue Pt A
container_start_page 1
container_title Experimental neurology
container_volume 283
creator McKillop, William M.
York, Elisa M.
Rubinger, Luc
Liu, Tony
Ossowski, Natalie M.
Xu, Kathy
Hryciw, Todd
Brown, Arthur
description The absence of axonal regeneration after spinal cord injury (SCI) has been attributed to the up-regulation of axon-repelling molecules, such as chondroitin sulfate proteoglycans (CSPGs) present in the glial scar that forms post-SCI. We previously identified the transcription factor SOX9 as a key up-regulator of CSPG production and also demonstrated that conditional Sox9 ablation leads to decreased CSPG levels and improved recovery of hind limb function after SCI. We herein demonstrate increased neural input onto spinal neurons caudal to the lesion in spinal cord injured Sox9 conditional knock out mice as indicated by increased levels of the presynaptic markers synaptophysin and vesicular glutamate transporter 1 (VGLUT1) compared to controls. Axonal sparing, long-range axonal regeneration and reactive sprouting were investigated as possible explanations for the increase in neural inputs caudal to the lesion and for the improved locomotor outcomes in spinal cord-injured Sox9 conditional knock out mice. Whereas retrograde tract-tracing studies failed to reveal any evidence for increased axonal sparing or for long-range regeneration in the Sox9 conditional knock out mice, anterograde tract-tracing experiments demonstrated increased reactive sprouting caudal to the lesion after SCI. Finally we demonstrate that application of a broad spectrum MMP inhibitor to reduce CSPG degradation in Sox9 conditional knock out mice prevents the improvements in locomotor recovery observed in untreated Sox9 conditional knock out mice. These results suggest that improved recovery of locomotor function in Sox9 conditional knock out mice after SCI is due to increased reactive sprouting secondary to reduced CSPG levels distal to the lesion. •Cord-injured Sox9 knock outs recover more inputs caudal to the lesion than controls.•The increased neural inputs are not due to increased sparing or regeneration.•Sox9 knock out mice have more reactive sprouting than controls.•Doxycycline stabilizes CSPG levels and diminishes locomotor recovery in these mice.
doi_str_mv 10.1016/j.expneurol.2016.05.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1813627334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488616301467</els_id><sourcerecordid>1813627334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-5063cb68518cd2bcb29724b69b9acc8c7962b15351fee2055f6877a8f471dd1b3</originalsourceid><addsrcrecordid>eNqFkM1PwyAchonRuDn9F7RHL618lEKPZvErWeJBPROgvxqWtkxoF_ffyzLd1RPw8vx4w4PQDcEFwaS6WxfwvRlgCr4raAoKzAtM5QmaE1zjnJYMn6I5xqTMSymrGbqIcY0xrksqztGMCsp4zdgc-aUfGjc6P-gue_PfdaZNp_fnzPWb4LcQs85b3_vRhyyATUnYZbodIWRx4_Zj1ocmc8N6Shdml3Y2gI5u-Ey8tqPbQiKDn8YUXaKzVncRrn7XBfp4fHhfPuer16eX5f0qt0yQMee4YtZUkhNpG2qsobWgpalqU2trpRV1RQ3hjJMWgGLO20oKoWVbCtI0xLAFuj28m4q_Joij6l200HV6AD9FRSRhFRWMlQkVB9QGH2OAVm2C63XYKYLV3rZaq6NttbetMFfJdpq8_i2ZTA_Nce5PbwLuDwCkr24dBBWtg8FC45LKUTXe_VvyA_49mBY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1813627334</pqid></control><display><type>article</type><title>Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>McKillop, William M. ; York, Elisa M. ; Rubinger, Luc ; Liu, Tony ; Ossowski, Natalie M. ; Xu, Kathy ; Hryciw, Todd ; Brown, Arthur</creator><creatorcontrib>McKillop, William M. ; York, Elisa M. ; Rubinger, Luc ; Liu, Tony ; Ossowski, Natalie M. ; Xu, Kathy ; Hryciw, Todd ; Brown, Arthur</creatorcontrib><description>The absence of axonal regeneration after spinal cord injury (SCI) has been attributed to the up-regulation of axon-repelling molecules, such as chondroitin sulfate proteoglycans (CSPGs) present in the glial scar that forms post-SCI. We previously identified the transcription factor SOX9 as a key up-regulator of CSPG production and also demonstrated that conditional Sox9 ablation leads to decreased CSPG levels and improved recovery of hind limb function after SCI. We herein demonstrate increased neural input onto spinal neurons caudal to the lesion in spinal cord injured Sox9 conditional knock out mice as indicated by increased levels of the presynaptic markers synaptophysin and vesicular glutamate transporter 1 (VGLUT1) compared to controls. Axonal sparing, long-range axonal regeneration and reactive sprouting were investigated as possible explanations for the increase in neural inputs caudal to the lesion and for the improved locomotor outcomes in spinal cord-injured Sox9 conditional knock out mice. Whereas retrograde tract-tracing studies failed to reveal any evidence for increased axonal sparing or for long-range regeneration in the Sox9 conditional knock out mice, anterograde tract-tracing experiments demonstrated increased reactive sprouting caudal to the lesion after SCI. Finally we demonstrate that application of a broad spectrum MMP inhibitor to reduce CSPG degradation in Sox9 conditional knock out mice prevents the improvements in locomotor recovery observed in untreated Sox9 conditional knock out mice. These results suggest that improved recovery of locomotor function in Sox9 conditional knock out mice after SCI is due to increased reactive sprouting secondary to reduced CSPG levels distal to the lesion. •Cord-injured Sox9 knock outs recover more inputs caudal to the lesion than controls.•The increased neural inputs are not due to increased sparing or regeneration.•Sox9 knock out mice have more reactive sprouting than controls.•Doxycycline stabilizes CSPG levels and diminishes locomotor recovery in these mice.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2016.05.028</identifier><identifier>PMID: 27235933</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Axons - drug effects ; Axons - pathology ; Biotin - analogs &amp; derivatives ; Biotin - pharmacokinetics ; Chondroitin Sulfate Proteoglycans - genetics ; Chondroitin Sulfate Proteoglycans - metabolism ; CSPG ; Dextrans - pharmacokinetics ; Disease Models, Animal ; Doxycycline - pharmacology ; Doxycycline - therapeutic use ; Edema - etiology ; Enzyme Inhibitors - pharmacology ; Enzyme Inhibitors - therapeutic use ; Humans ; Locomotion - genetics ; Locomotion - physiology ; Mice ; Nerve Tissue Proteins - metabolism ; Neuroplasticity ; Perineuronal nets ; Reactive sprouting ; Receptors, Estrogen - genetics ; Receptors, Estrogen - metabolism ; Recovery of Function - genetics ; Recovery of Function - physiology ; SOX9 ; SOX9 Transcription Factor - genetics ; SOX9 Transcription Factor - metabolism ; Spinal Cord Injuries - drug therapy ; Spinal Cord Injuries - genetics ; Spinal Cord Injuries - pathology ; Spinal Cord Injuries - physiopathology ; Spinal cord injury ; Stilbamidines - pharmacokinetics ; Synaptophysin - genetics ; Synaptophysin - metabolism ; Time Factors ; Up-Regulation - genetics ; Vesicular Glutamate Transport Protein 1 - genetics ; Vesicular Glutamate Transport Protein 1 - metabolism</subject><ispartof>Experimental neurology, 2016-09, Vol.283 (Pt A), p.1-15</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-5063cb68518cd2bcb29724b69b9acc8c7962b15351fee2055f6877a8f471dd1b3</citedby><cites>FETCH-LOGICAL-c371t-5063cb68518cd2bcb29724b69b9acc8c7962b15351fee2055f6877a8f471dd1b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014488616301467$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27235933$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McKillop, William M.</creatorcontrib><creatorcontrib>York, Elisa M.</creatorcontrib><creatorcontrib>Rubinger, Luc</creatorcontrib><creatorcontrib>Liu, Tony</creatorcontrib><creatorcontrib>Ossowski, Natalie M.</creatorcontrib><creatorcontrib>Xu, Kathy</creatorcontrib><creatorcontrib>Hryciw, Todd</creatorcontrib><creatorcontrib>Brown, Arthur</creatorcontrib><title>Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>The absence of axonal regeneration after spinal cord injury (SCI) has been attributed to the up-regulation of axon-repelling molecules, such as chondroitin sulfate proteoglycans (CSPGs) present in the glial scar that forms post-SCI. We previously identified the transcription factor SOX9 as a key up-regulator of CSPG production and also demonstrated that conditional Sox9 ablation leads to decreased CSPG levels and improved recovery of hind limb function after SCI. We herein demonstrate increased neural input onto spinal neurons caudal to the lesion in spinal cord injured Sox9 conditional knock out mice as indicated by increased levels of the presynaptic markers synaptophysin and vesicular glutamate transporter 1 (VGLUT1) compared to controls. Axonal sparing, long-range axonal regeneration and reactive sprouting were investigated as possible explanations for the increase in neural inputs caudal to the lesion and for the improved locomotor outcomes in spinal cord-injured Sox9 conditional knock out mice. Whereas retrograde tract-tracing studies failed to reveal any evidence for increased axonal sparing or for long-range regeneration in the Sox9 conditional knock out mice, anterograde tract-tracing experiments demonstrated increased reactive sprouting caudal to the lesion after SCI. Finally we demonstrate that application of a broad spectrum MMP inhibitor to reduce CSPG degradation in Sox9 conditional knock out mice prevents the improvements in locomotor recovery observed in untreated Sox9 conditional knock out mice. These results suggest that improved recovery of locomotor function in Sox9 conditional knock out mice after SCI is due to increased reactive sprouting secondary to reduced CSPG levels distal to the lesion. •Cord-injured Sox9 knock outs recover more inputs caudal to the lesion than controls.•The increased neural inputs are not due to increased sparing or regeneration.•Sox9 knock out mice have more reactive sprouting than controls.•Doxycycline stabilizes CSPG levels and diminishes locomotor recovery in these mice.</description><subject>Animals</subject><subject>Axons - drug effects</subject><subject>Axons - pathology</subject><subject>Biotin - analogs &amp; derivatives</subject><subject>Biotin - pharmacokinetics</subject><subject>Chondroitin Sulfate Proteoglycans - genetics</subject><subject>Chondroitin Sulfate Proteoglycans - metabolism</subject><subject>CSPG</subject><subject>Dextrans - pharmacokinetics</subject><subject>Disease Models, Animal</subject><subject>Doxycycline - pharmacology</subject><subject>Doxycycline - therapeutic use</subject><subject>Edema - etiology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Humans</subject><subject>Locomotion - genetics</subject><subject>Locomotion - physiology</subject><subject>Mice</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Neuroplasticity</subject><subject>Perineuronal nets</subject><subject>Reactive sprouting</subject><subject>Receptors, Estrogen - genetics</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Recovery of Function - genetics</subject><subject>Recovery of Function - physiology</subject><subject>SOX9</subject><subject>SOX9 Transcription Factor - genetics</subject><subject>SOX9 Transcription Factor - metabolism</subject><subject>Spinal Cord Injuries - drug therapy</subject><subject>Spinal Cord Injuries - genetics</subject><subject>Spinal Cord Injuries - pathology</subject><subject>Spinal Cord Injuries - physiopathology</subject><subject>Spinal cord injury</subject><subject>Stilbamidines - pharmacokinetics</subject><subject>Synaptophysin - genetics</subject><subject>Synaptophysin - metabolism</subject><subject>Time Factors</subject><subject>Up-Regulation - genetics</subject><subject>Vesicular Glutamate Transport Protein 1 - genetics</subject><subject>Vesicular Glutamate Transport Protein 1 - metabolism</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1PwyAchonRuDn9F7RHL618lEKPZvErWeJBPROgvxqWtkxoF_ffyzLd1RPw8vx4w4PQDcEFwaS6WxfwvRlgCr4raAoKzAtM5QmaE1zjnJYMn6I5xqTMSymrGbqIcY0xrksqztGMCsp4zdgc-aUfGjc6P-gue_PfdaZNp_fnzPWb4LcQs85b3_vRhyyATUnYZbodIWRx4_Zj1ocmc8N6Shdml3Y2gI5u-Ey8tqPbQiKDn8YUXaKzVncRrn7XBfp4fHhfPuer16eX5f0qt0yQMee4YtZUkhNpG2qsobWgpalqU2trpRV1RQ3hjJMWgGLO20oKoWVbCtI0xLAFuj28m4q_Joij6l200HV6AD9FRSRhFRWMlQkVB9QGH2OAVm2C63XYKYLV3rZaq6NttbetMFfJdpq8_i2ZTA_Nce5PbwLuDwCkr24dBBWtg8FC45LKUTXe_VvyA_49mBY</recordid><startdate>201609</startdate><enddate>201609</enddate><creator>McKillop, William M.</creator><creator>York, Elisa M.</creator><creator>Rubinger, Luc</creator><creator>Liu, Tony</creator><creator>Ossowski, Natalie M.</creator><creator>Xu, Kathy</creator><creator>Hryciw, Todd</creator><creator>Brown, Arthur</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201609</creationdate><title>Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting</title><author>McKillop, William M. ; York, Elisa M. ; Rubinger, Luc ; Liu, Tony ; Ossowski, Natalie M. ; Xu, Kathy ; Hryciw, Todd ; Brown, Arthur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-5063cb68518cd2bcb29724b69b9acc8c7962b15351fee2055f6877a8f471dd1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Axons - drug effects</topic><topic>Axons - pathology</topic><topic>Biotin - analogs &amp; derivatives</topic><topic>Biotin - pharmacokinetics</topic><topic>Chondroitin Sulfate Proteoglycans - genetics</topic><topic>Chondroitin Sulfate Proteoglycans - metabolism</topic><topic>CSPG</topic><topic>Dextrans - pharmacokinetics</topic><topic>Disease Models, Animal</topic><topic>Doxycycline - pharmacology</topic><topic>Doxycycline - therapeutic use</topic><topic>Edema - etiology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Humans</topic><topic>Locomotion - genetics</topic><topic>Locomotion - physiology</topic><topic>Mice</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Neuroplasticity</topic><topic>Perineuronal nets</topic><topic>Reactive sprouting</topic><topic>Receptors, Estrogen - genetics</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Recovery of Function - genetics</topic><topic>Recovery of Function - physiology</topic><topic>SOX9</topic><topic>SOX9 Transcription Factor - genetics</topic><topic>SOX9 Transcription Factor - metabolism</topic><topic>Spinal Cord Injuries - drug therapy</topic><topic>Spinal Cord Injuries - genetics</topic><topic>Spinal Cord Injuries - pathology</topic><topic>Spinal Cord Injuries - physiopathology</topic><topic>Spinal cord injury</topic><topic>Stilbamidines - pharmacokinetics</topic><topic>Synaptophysin - genetics</topic><topic>Synaptophysin - metabolism</topic><topic>Time Factors</topic><topic>Up-Regulation - genetics</topic><topic>Vesicular Glutamate Transport Protein 1 - genetics</topic><topic>Vesicular Glutamate Transport Protein 1 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McKillop, William M.</creatorcontrib><creatorcontrib>York, Elisa M.</creatorcontrib><creatorcontrib>Rubinger, Luc</creatorcontrib><creatorcontrib>Liu, Tony</creatorcontrib><creatorcontrib>Ossowski, Natalie M.</creatorcontrib><creatorcontrib>Xu, Kathy</creatorcontrib><creatorcontrib>Hryciw, Todd</creatorcontrib><creatorcontrib>Brown, Arthur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McKillop, William M.</au><au>York, Elisa M.</au><au>Rubinger, Luc</au><au>Liu, Tony</au><au>Ossowski, Natalie M.</au><au>Xu, Kathy</au><au>Hryciw, Todd</au><au>Brown, Arthur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2016-09</date><risdate>2016</risdate><volume>283</volume><issue>Pt A</issue><spage>1</spage><epage>15</epage><pages>1-15</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><abstract>The absence of axonal regeneration after spinal cord injury (SCI) has been attributed to the up-regulation of axon-repelling molecules, such as chondroitin sulfate proteoglycans (CSPGs) present in the glial scar that forms post-SCI. We previously identified the transcription factor SOX9 as a key up-regulator of CSPG production and also demonstrated that conditional Sox9 ablation leads to decreased CSPG levels and improved recovery of hind limb function after SCI. We herein demonstrate increased neural input onto spinal neurons caudal to the lesion in spinal cord injured Sox9 conditional knock out mice as indicated by increased levels of the presynaptic markers synaptophysin and vesicular glutamate transporter 1 (VGLUT1) compared to controls. Axonal sparing, long-range axonal regeneration and reactive sprouting were investigated as possible explanations for the increase in neural inputs caudal to the lesion and for the improved locomotor outcomes in spinal cord-injured Sox9 conditional knock out mice. Whereas retrograde tract-tracing studies failed to reveal any evidence for increased axonal sparing or for long-range regeneration in the Sox9 conditional knock out mice, anterograde tract-tracing experiments demonstrated increased reactive sprouting caudal to the lesion after SCI. Finally we demonstrate that application of a broad spectrum MMP inhibitor to reduce CSPG degradation in Sox9 conditional knock out mice prevents the improvements in locomotor recovery observed in untreated Sox9 conditional knock out mice. These results suggest that improved recovery of locomotor function in Sox9 conditional knock out mice after SCI is due to increased reactive sprouting secondary to reduced CSPG levels distal to the lesion. •Cord-injured Sox9 knock outs recover more inputs caudal to the lesion than controls.•The increased neural inputs are not due to increased sparing or regeneration.•Sox9 knock out mice have more reactive sprouting than controls.•Doxycycline stabilizes CSPG levels and diminishes locomotor recovery in these mice.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27235933</pmid><doi>10.1016/j.expneurol.2016.05.028</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2016-09, Vol.283 (Pt A), p.1-15
issn 0014-4886
1090-2430
language eng
recordid cdi_proquest_miscellaneous_1813627334
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Axons - drug effects
Axons - pathology
Biotin - analogs & derivatives
Biotin - pharmacokinetics
Chondroitin Sulfate Proteoglycans - genetics
Chondroitin Sulfate Proteoglycans - metabolism
CSPG
Dextrans - pharmacokinetics
Disease Models, Animal
Doxycycline - pharmacology
Doxycycline - therapeutic use
Edema - etiology
Enzyme Inhibitors - pharmacology
Enzyme Inhibitors - therapeutic use
Humans
Locomotion - genetics
Locomotion - physiology
Mice
Nerve Tissue Proteins - metabolism
Neuroplasticity
Perineuronal nets
Reactive sprouting
Receptors, Estrogen - genetics
Receptors, Estrogen - metabolism
Recovery of Function - genetics
Recovery of Function - physiology
SOX9
SOX9 Transcription Factor - genetics
SOX9 Transcription Factor - metabolism
Spinal Cord Injuries - drug therapy
Spinal Cord Injuries - genetics
Spinal Cord Injuries - pathology
Spinal Cord Injuries - physiopathology
Spinal cord injury
Stilbamidines - pharmacokinetics
Synaptophysin - genetics
Synaptophysin - metabolism
Time Factors
Up-Regulation - genetics
Vesicular Glutamate Transport Protein 1 - genetics
Vesicular Glutamate Transport Protein 1 - metabolism
title Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A46%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conditional%20Sox9%20ablation%20improves%20locomotor%20recovery%20after%20spinal%20cord%20injury%20by%20increasing%20reactive%20sprouting&rft.jtitle=Experimental%20neurology&rft.au=McKillop,%20William%20M.&rft.date=2016-09&rft.volume=283&rft.issue=Pt%20A&rft.spage=1&rft.epage=15&rft.pages=1-15&rft.issn=0014-4886&rft.eissn=1090-2430&rft_id=info:doi/10.1016/j.expneurol.2016.05.028&rft_dat=%3Cproquest_cross%3E1813627334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1813627334&rft_id=info:pmid/27235933&rft_els_id=S0014488616301467&rfr_iscdi=true